A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

NCT ID: NCT00451906

Last Updated: 2016-05-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

2252 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-08-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single arm study will assess the safety and efficacy of Avastin combined with platinum-containing chemotherapy regimens in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC). Avastin will be given as first-line treatment in combination with platinum-based chemotherapy or in combination with any standard of care NSCLC first-line chemotherapy used in line with the licensed national prescribing information. Eligible patients will receive Avastin (15mg/kg iv on day 1 of each 3 week cycle) concomitantly with chemotherapy. Avastin treatment will continue after completion of chemotherapy cycles until disease progression, and the target sample size is 500+ individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Squamous Non-Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bevacizumab + Chemotherapy

Participants with advanced or recurrent NSCLC will be administered bevacizumab infusions at a dose of 7.5 milligram per kilogram (mg/kg) or 15 mg/kg (investigator's choice) on Day 1 and then every 3 weeks, intravenously (IV) for a maximum of 6 cycles in combination with the standard of care NSCLC first-line chemotherapy in line with the licensed national prescribing information, during the treatment period. The initial dose of bevacizumab will be administered following chemotherapy; all subsequent doses could be given before or after chemotherapy.

Group Type EXPERIMENTAL

Platinum-based chemotherapy

Intervention Type DRUG

As prescribed

Bevacizumab [Avastin]

Intervention Type DRUG

15 mg/kg IV on Day 1 of each 3 week cycle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platinum-based chemotherapy

As prescribed

Intervention Type DRUG

Bevacizumab [Avastin]

15 mg/kg IV on Day 1 of each 3 week cycle

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients, \>=18 years of age;
* histologically or cytologically documented inoperable, locally advanced ( stage III), metastatic (stage IV) or recurrent NSCLC other than squamous cell (tumors of mixed histology should be categorized by the predominant cell type);
* ECOG PS status 0-2;
* life expectancy \>= 12weeks;
* adequate renal, liver and hematological function.

Exclusion Criteria

* mixed, non-small and small cell tumors, or mixed adenosquamous carcinomas with a predominant squamous component;
* hemoptysis (\>=1/2 teaspoon of bright red blood) in previous 3 months;
* evidence of tumor invading major blood vessels on imaging;
* evidence of CNS metastases, even if previously treated.
* major surgery (including open biopsy), significant traumatic injury within 28 days prior to enrolment, or anticipation of need for major surgery during study treatment;
* prior chemotherapy for stage IIIb/IV disease.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Buenos Aires, , Argentina

Site Status

Chaco-resistencia, , Argentina

Site Status

Córdoba, , Argentina

Site Status

Córdoba, , Argentina

Site Status

San Miguel de Tucumán, , Argentina

Site Status

St Leonards, New South Wales, Australia

Site Status

Waratah, New South Wales, Australia

Site Status

Auchenflower, Queensland, Australia

Site Status

Chermside, Queensland, Australia

Site Status

Tugun, Queensland, Australia

Site Status

Box Hill, Victoria, Australia

Site Status

Geelong, Victoria, Australia

Site Status

Malvern, Victoria, Australia

Site Status

Wodonga, Victoria, Australia

Site Status

Perth, Western Australia, Australia

Site Status

Sydney, New South Wales, , Australia

Site Status

Bludesch, , Austria

Site Status

Bregenz, , Austria

Site Status

Feldkirch, , Austria

Site Status

Graz, , Austria

Site Status

Innsbruck, , Austria

Site Status

Knittelfeld, , Austria

Site Status

Kufstein, , Austria

Site Status

Linz, , Austria

Site Status

Linz, , Austria

Site Status

Natters, , Austria

Site Status

Salzburg, , Austria

Site Status

Sankt Veit an der Glan, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Vöcklabruck, , Austria

Site Status

Wels, , Austria

Site Status

Zams, , Austria

Site Status

Banja Luka, , Bosnia and Herzegovina

Site Status

Sarajevo, , Bosnia and Herzegovina

Site Status

Fortaleza, Ceará, Brazil

Site Status

Vitória, Espírito Santo, Brazil

Site Status

Salvador, Bahia, Estado de Bahia, Brazil

Site Status

Goiânia, Goiás, Brazil

Site Status

Belo Horizonte, Minas Gerais, Brazil

Site Status

Belo Horizonte, Minas Gerais, Brazil

Site Status

Recife, Pernambuco, Brazil

Site Status

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Ijuí, Rio Grande do Sul, Brazil

Site Status

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Campinas, São Paulo, Brazil

Site Status

Campinas, São Paulo, Brazil

Site Status

Jaú, São Paulo, Brazil

Site Status

Ribeirão Preto, São Paulo, Brazil

Site Status

Santos, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

Vancouver, British Columbia, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Beijing, , China

Site Status

Beijing, , China

Site Status

Beijing, , China

Site Status

Guangzhou, , China

Site Status

Guangzhou, , China

Site Status

Hangzhou, , China

Site Status

Shanghai, , China

Site Status

Shanghai, , China

Site Status

Bogotá, , Colombia

Site Status

Cali, , Colombia

Site Status

Manizales, , Colombia

Site Status

Brno, , Czechia

Site Status

Pilsen, , Czechia

Site Status

Prague, , Czechia

Site Status

Aarhus, , Denmark

Site Status

Herlev, , Denmark

Site Status

Hillerød, , Denmark

Site Status

Næstved, , Denmark

Site Status

Guayaquil, , Ecuador

Site Status

Quito, , Ecuador

Site Status

Cairo, , Egypt

Site Status

Cairo, , Egypt

Site Status

Tallinn, , Estonia

Site Status

Tartu, , Estonia

Site Status

Helsinki, , Finland

Site Status

Paimio, , Finland

Site Status

Pori, , Finland

Site Status

Tampere, , Finland

Site Status

Aix-en-Provence, , France

Site Status

Avignon, , France

Site Status

Besançon, , France

Site Status

Béziers, , France

Site Status

Bordeaux, , France

Site Status

Brest, , France

Site Status

Caen, , France

Site Status

Chalon-sur-Saône, , France

Site Status

Clermont-Ferrand, , France

Site Status

Gap, , France

Site Status

Grenoble, , France

Site Status

Le Chesnay, , France

Site Status

Lille, , France

Site Status

Lille, , France

Site Status

Lille, , France

Site Status

Lyon, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Meaux, , France

Site Status

Nancy, , France

Site Status

Neuilly-sur-Seine, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Perpignan, , France

Site Status

Reims, , France

Site Status

Saint-Julien-en-Genevois, , France

Site Status

Strasbourg, , France

Site Status

Strasbourg, , France

Site Status

Toulon, , France

Site Status

Toulon, , France

Site Status

Toulouse, , France

Site Status

Toulouse, , France

Site Status

Valenciennes, , France

Site Status

Vandœuvre-lès-Nancy, , France

Site Status

Augsburg, , Germany

Site Status

Bad Berka, , Germany

Site Status

Bayreuth, , Germany

Site Status

Berlin, , Germany

Site Status

Berlin, , Germany

Site Status

Berlin, , Germany

Site Status

Bielefeld, , Germany

Site Status

Bonn, , Germany

Site Status

Cologne, , Germany

Site Status

Coswig, , Germany

Site Status

Donaustauf, , Germany

Site Status

Düsseldorf, , Germany

Site Status

Ebensfeld, , Germany

Site Status

Erlangen, , Germany

Site Status

Essen, , Germany

Site Status

Frankfurt, , Germany

Site Status

Freiburg im Breisgau, , Germany

Site Status

Gauting, , Germany

Site Status

Gerlingen, , Germany

Site Status

Göttingen, , Germany

Site Status

Großhansdorf, , Germany

Site Status

Halle, , Germany

Site Status

Hamburg, , Germany

Site Status

Hamburg, , Germany

Site Status

Hanover, , Germany

Site Status

Hanover, , Germany

Site Status

Karlsruhe, , Germany

Site Status

Kiel, , Germany

Site Status

Leer, , Germany

Site Status

Leipzig, , Germany

Site Status

Leverkusen, , Germany

Site Status

Löwenstein, , Germany

Site Status

Magdeburg, , Germany

Site Status

Mainz, , Germany

Site Status

Minden, , Germany

Site Status

München, , Germany

Site Status

Neuruppin, , Germany

Site Status

Nuremberg, , Germany

Site Status

Oldenburg, , Germany

Site Status

Rostock, , Germany

Site Status

Treuenbrietzen, , Germany

Site Status

Ulm, , Germany

Site Status

Villingen-Schwenningen, , Germany

Site Status

Wiesbaden, , Germany

Site Status

Wolfsburg, , Germany

Site Status

Würselen, , Germany

Site Status

Hong Kong, , Hong Kong

Site Status

Hong Kong, , Hong Kong

Site Status

Shatin, , Hong Kong

Site Status

Budapest, , Hungary

Site Status

Mátraháza, , Hungary

Site Status

Pécs, , Hungary

Site Status

Szombathely, , Hungary

Site Status

Törökbálint, , Hungary

Site Status

Reykjavik, , Iceland

Site Status

Beersheba, , Israel

Site Status

Haifa, , Israel

Site Status

Jerusalem, , Israel

Site Status

Jerusalem, , Israel

Site Status

Kfar Saba, , Israel

Site Status

Ramat Gan, , Israel

Site Status

Tel Aviv, , Israel

Site Status

Ẕerifin, , Israel

Site Status

Avezzano, Abruzzo, Italy

Site Status

Pescara, Abruzzo, Italy

Site Status

Bari, Apulia, Italy

Site Status

Brindisi, Apulia, Italy

Site Status

San Giovanni Rotondo, Apulia, Italy

Site Status

Potenza, Basilicate, Italy

Site Status

Rionero in Vulture, Basilicate, Italy

Site Status

Catanzaro, Calabria, Italy

Site Status

Avellino, Campania, Italy

Site Status

Napoli, Campania, Italy

Site Status

Bologna, Emilia-Romagna, Italy

Site Status

Carpi, Emilia-Romagna, Italy

Site Status

Modena, Emilia-Romagna, Italy

Site Status

Rimini, Emilia-Romagna, Italy

Site Status

Aviano, Friuli Venezia Giulia, Italy

Site Status

Udine, Friuli Venezia Giulia, Italy

Site Status

Rome, Lazio, Italy

Site Status

Rome, Lazio, Italy

Site Status

Rome, Lazio, Italy

Site Status

Sora, Lazio, Italy

Site Status

Viterbo, Lazio, Italy

Site Status

Genoa, Liguria, Italy

Site Status

Genoa, Liguria, Italy

Site Status

La Spezia, Liguria, Italy

Site Status

Bergamo, Lombardy, Italy

Site Status

Cremona, Lombardy, Italy

Site Status

Milan, Lombardy, Italy

Site Status

Milan, Lombardy, Italy

Site Status

Pavia, Lombardy, Italy

Site Status

S Fermo Della Battaglia, Lombardy, Italy

Site Status

Sondrio, Lombardy, Italy

Site Status

Novara, Piedmont, Italy

Site Status

Cagliari, Sardinia, Italy

Site Status

Sassari, Sardinia, Italy

Site Status

Catania, Sicily, Italy

Site Status

Catania, Sicily, Italy

Site Status

Palermo, Sicily, Italy

Site Status

Taormina, Sicily, Italy

Site Status

Ancona, The Marches, Italy

Site Status

Arezzo, Tuscany, Italy

Site Status

Lido di Camaiore, Tuscany, Italy

Site Status

Pisa, Tuscany, Italy

Site Status

Camposampiero, Veneto, Italy

Site Status

Feltre - Bl, Veneto, Italy

Site Status

Negrar, Veneto, Italy

Site Status

Bologna, Umbria, , Italy

Site Status

Forli, Emilia-Romagna, , Italy

Site Status

Riga, , Latvia

Site Status

Riga, , Latvia

Site Status

Beirut, , Lebanon

Site Status

Kaunas, , Lithuania

Site Status

Klaipėda, , Lithuania

Site Status

Vilnius, , Lithuania

Site Status

Chihuahua City, , Mexico

Site Status

León, , Mexico

Site Status

Mexico City, , Mexico

Site Status

Mexico City, , Mexico

Site Status

Arnhem, , Netherlands

Site Status

Breda, , Netherlands

Site Status

Eindhoven, , Netherlands

Site Status

Groningen, , Netherlands

Site Status

Haarlem, , Netherlands

Site Status

Helmond, , Netherlands

Site Status

Hoofddorp, , Netherlands

Site Status

Nieuwegein, , Netherlands

Site Status

Schiedam, , Netherlands

Site Status

The Hague, , Netherlands

Site Status

Tiel, , Netherlands

Site Status

Zwolle, , Netherlands

Site Status

Bialystok, , Poland

Site Status

Krakow, , Poland

Site Status

Lublin, , Poland

Site Status

Poznan, , Poland

Site Status

Warsaw, , Poland

Site Status

Warsaw, , Poland

Site Status

Zabrze, , Poland

Site Status

Braga, , Portugal

Site Status

Coimbra, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Porto, , Portugal

Site Status

Porto, , Portugal

Site Status

Santa Maria da Feira, , Portugal

Site Status

Setúbal, , Portugal

Site Status

Vila Nova de Gaia, , Portugal

Site Status

Bucharest, , Romania

Site Status

Cluj-Napoca, , Romania

Site Status

Timișoara, , Romania

Site Status

Balashikha, , Russia

Site Status

Engel's, , Russia

Site Status

Irkutsk, , Russia

Site Status

Kislino, Kursk Region, , Russia

Site Status

Krasnodar, , Russia

Site Status

Moscow, , Russia

Site Status

Moscow, , Russia

Site Status

Moscow, , Russia

Site Status

Samara, , Russia

Site Status

Smolensk, , Russia

Site Status

Stavropol, , Russia

Site Status

Tver', , Russia

Site Status

Tyumen, , Russia

Site Status

Ulyanovsk, , Russia

Site Status

Belgrade, , Serbia

Site Status

Bratislava, , Slovakia

Site Status

Košice, , Slovakia

Site Status

Nitra, , Slovakia

Site Status

Poprad, , Slovakia

Site Status

Golnik, , Slovenia

Site Status

Ljubljana, , Slovenia

Site Status

Alicante, Alicante, Spain

Site Status

Elche, Alicante, Spain

Site Status

Palma de Mallorca, Balearic Islands, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Manresa, Barcelona, Spain

Site Status

Mataró, Barcelona, Spain

Site Status

Sabadell, Barcelona, Spain

Site Status

Terrassa, Barcelona, Spain

Site Status

Santander, Cantabria, Spain

Site Status

Girona, Girona, Spain

Site Status

Huesca, Huesca, Spain

Site Status

A Coruña, La Coruña, Spain

Site Status

Lugo, Lugo, Spain

Site Status

Alcorcón, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Murcia, Murcia, Spain

Site Status

Pamplona, Navarre, Spain

Site Status

Salamanca, Salamanca, Spain

Site Status

San Cristóbal de La Laguna, Tenerife, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Barakaldo, Vizcaya, Spain

Site Status

Zaragoza, Zaragoza, Spain

Site Status

Gothenburg, , Sweden

Site Status

Lund, , Sweden

Site Status

Malmo, , Sweden

Site Status

Örebro, , Sweden

Site Status

Stokholm, Solna, , Sweden

Site Status

Umeå, , Sweden

Site Status

Uppsala, , Sweden

Site Status

Aarau, , Switzerland

Site Status

Baden, , Switzerland

Site Status

Genolier, , Switzerland

Site Status

Locarno, , Switzerland

Site Status

Taichung, , Taiwan

Site Status

Tainan City, , Taiwan

Site Status

Taipei, , Taiwan

Site Status

Taipei, , Taiwan

Site Status

Taoyuan District, , Taiwan

Site Status

Ankara, , Turkey (Türkiye)

Site Status

Gaziantep, , Turkey (Türkiye)

Site Status

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul, , Turkey (Türkiye)

Site Status

Izmir, , Turkey (Türkiye)

Site Status

Sıhhiye, Ankara, , Turkey (Türkiye)

Site Status

Aberdeen, , United Kingdom

Site Status

Belfast, , United Kingdom

Site Status

Birmingham, , United Kingdom

Site Status

Cambridge, , United Kingdom

Site Status

Cardiff, , United Kingdom

Site Status

Manchester, , United Kingdom

Site Status

Nottingham, , United Kingdom

Site Status

Suffolk, , United Kingdom

Site Status

Barcelona, , Venezuela

Site Status

Barquisimeto, , Venezuela

Site Status

Porlamar, , Venezuela

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina Australia Austria Bosnia and Herzegovina Brazil Canada China Colombia Czechia Denmark Ecuador Egypt Estonia Finland France Germany Hong Kong Hungary Iceland Israel Italy Latvia Lebanon Lithuania Mexico Netherlands Poland Portugal Romania Russia Serbia Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey (Türkiye) United Kingdom Venezuela

References

Explore related publications, articles, or registry entries linked to this study.

Bearz A, Passalacqua R, Alabiso O, Cinieri S, Gridelli C, Cravesana C, Crino L. First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study. Clin Drug Investig. 2012 Nov;32(11):755-60. doi: 10.1007/s40261-012-0001-9.

Reference Type DERIVED
PMID: 23018280 (View on PubMed)

Crino L, Dansin E, Garrido P, Griesinger F, Laskin J, Pavlakis N, Stroiakovski D, Thatcher N, Tsai CM, Wu YL, Zhou C. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study. Lancet Oncol. 2010 Aug;11(8):733-40. doi: 10.1016/S1470-2045(10)70151-0. Epub 2010 Jul 23.

Reference Type DERIVED
PMID: 20650686 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MO19390

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.